Wilmot Cancer Institute, University of Rochester — Rochester, New York

Wilmot Cancer Institute, University of Rochester is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

Wilmot Cancer Institute, University of Rochester has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: AML, AML With Mutated NPM1, Hematologic Malignancy.

Sponsors: Kura Oncology, Inc., Protagonist Therapeutics, Inc., Syntrix Biosystems, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in New York · View every site in Rochester

• University of Rochester Medical Center, Alzheimer's Disease Center
• University of Rochester Medicine Otolaryngology
• University of Rochester, Eastman Dept of Dentistry
• Golisano Children's Hospital at Strong
• University of Rochester Medical Center/Flaum Eye Institute
• University of Rochester Sleep Research Laboratory
• University of Rochester Medical Center /ID# 213527
• University of Rochester, Department of Neurology
• University of RochesterJames P. Wilmont Cancer Center
• University Radiation Oncology
• Rochester General Hospital's Lipson Cancer and Blood Center
• Multiple Sclerosis Center, University of Rochester Medical Center

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wilmot Cancer Institute, University of Rochester?

Wilmot Cancer Institute, University of Rochester has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wilmot Cancer Institute, University of Rochester conducted?

Wilmot Cancer Institute, University of Rochester has 4 clinical trials on record, with 4 currently active. Their work covers AML, AML With Mutated NPM1, Hematologic Malignancy.

Is Wilmot Cancer Institute, University of Rochester accredited by Crixeo Clinical Trials?

Wilmot Cancer Institute, University of Rochester has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wilmot Cancer Institute, University of Rochester?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.